Jasper Therapeutics, Inc. · NASDAQ:JSPR
Morgan Stanley's stake in Jasper Therapeutics, Inc. fell to 2.80% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 7, 2025
Morgan Stanley's stake in Jasper Therapeutics, Inc. fell to 2.80%, 784,628 shares, as a passive investor on Sep 30, 2025. Filed Nov 7, 2025 (Schedule 13G/A).
- Stake
- 2.80%
- Shares
- 784,628
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 2.80% | 784,628 |
Source
Related
- Jasper Therapeutics, Inc.
- Morgan Stanley
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G · Morgan Stanley · Feb 11, 2026
- Schedule 13G · Morgan Stanley · Aug 6, 2025
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026